AKT1 and non-small cell lung carcinoma: Schmid [26] recently found that clathrin-mediated endocytosis (CME) in H1299 NSCLC cells is Drp1- (dynamin-related protein 1-) dependent and sensitive to Akt inhibition, indicating its potential as a therapeutic target for NSCLC treatment.